Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/214689
Title: Application of the adverse outcome pathway to identify molecular changes in prenatal brain programming induced by IUGR: Discoveries after EGCG exposure
Author: Kühne, Britta Anna
Teixidó Condomines, Elisabet
Ettcheto Arriola, Miren
Puig i Miquel, Teresa
Planas, Marta
Feliu, Lidia
Pla, Laura
Campuzano Uceda, María Victoria
Gratacós Solsona, Eduard
Fritsche, Ellen
Illa Armengol, Míriam
Barenys Espadaler, Marta
Keywords: Creixement fetal
Neurogenètica
Medicina prenatal
Fetal growth
Neurogenetics
Prenatal medicine
Issue Date: 9-Nov-2022
Publisher: Elsevier Ltd
Abstract: Following a multi-disciplinary approach integrating information from several experimental models we have collected new evidence supporting, expanding and redesigning the AOP "Disrupted laminin/int-β1 interaction leading to decreased cognitive function". Investigations in vitro in rabbit and rat neurospheres and in vivo in mice exposed to EGCG (epigallocatechin-gallate) during neurodevelopment are combined with in vitro evaluations in neural progenitor cells overexpressing int-β1 and literature information from int-β1 deficiency models. We have discovered for the first time that neural progenitor cells from intrauterine growth restricted (IUGR) animals overexpress int-β1 at gene and protein level and due to this change in prenatal brain programming they respond differently than control neurospheres to the exposure of EGCG, a compound triggering neural progenitor cell migration alterations. We have also identified that EGCG developmental exposure has deleterious effects on neuronal branching and arborization in vitro and in vivo. Our results warn that a thorough developmental neurotoxicity characterization of this and other catechin-based food supplements is needed before recommending their consumption during pregnancy.
Note: Reproducció del document publicat a: https://doi.org/10.1016/j.fct.2022.113506
It is part of: Food and Chemical Toxicology, 2022, vol. 170, num.113506
URI: http://hdl.handle.net/2445/214689
Related resource: https://doi.org/10.1016/j.fct.2022.113506
ISSN: 0278-6915
Appears in Collections:Articles publicats en revistes (Farmacologia, Toxicologia i Química Terapèutica)
Articles publicats en revistes (Institut de Neurociències (UBNeuro))

Files in This Item:
File Description SizeFormat 
253801.pdf6.74 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons